Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging

Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging Ann Surg Oncol (2018) 25:1880–1888 https://doi.org/10.1245/s10434-018-6453-2 OR IG INA L A R TIC L E – PA NC REATIC TU MO RS Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging 1,2 3 3 4 Willemieke S. Tummers, MD , Sarah E. Miller, BS , Nutte T. Teraphongphom, Ph.D , Adam Gomez, MD , 1 1 3 1 Idan Steinberg, Ph.D , David M. Huland, Ph.D , Steve Hong, MD , Sri-Rajasekhar Kothapalli, Ph.D , Alifia Hasan, 3 3 2 2 MBA , Robert Ertsey, M.Sc , Bert A. Bonsing, MD, PhD , Alexander L. Vahrmeijer, MD, PhD , Rutger- 2 4 5 6 Jan Swijnenburg, MD, PhD , Teri A. Longacre, MD , George A. Fisher, MD , Sanjiv S. Gambhir, MD, PhD , 7 3,8 George A. Poultsides, MD , and Eben L. Rosenthal, MD, FACS Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA; 2 3 Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Otolaryngology, 4 5 Stanford University, Stanford, CA; Department of Pathology, Stanford University, Stanford, CA; Department of Medical Oncology, Stanford University, Stanford, CA; Departments of Radiology, Bioengineering, and Materials Science & Engineering, Molecular Imaging Program http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging

Download PDF
9 pages

Loading next page...
 
/lp/springer_journal/intraoperative-pancreatic-cancer-detection-using-tumor-specific-7FP5l9SsOl
Publisher
Springer Journals
Copyright
Copyright © 2018 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
DOI
10.1245/s10434-018-6453-2
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2018) 25:1880–1888 https://doi.org/10.1245/s10434-018-6453-2 OR IG INA L A R TIC L E – PA NC REATIC TU MO RS Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging 1,2 3 3 4 Willemieke S. Tummers, MD , Sarah E. Miller, BS , Nutte T. Teraphongphom, Ph.D , Adam Gomez, MD , 1 1 3 1 Idan Steinberg, Ph.D , David M. Huland, Ph.D , Steve Hong, MD , Sri-Rajasekhar Kothapalli, Ph.D , Alifia Hasan, 3 3 2 2 MBA , Robert Ertsey, M.Sc , Bert A. Bonsing, MD, PhD , Alexander L. Vahrmeijer, MD, PhD , Rutger- 2 4 5 6 Jan Swijnenburg, MD, PhD , Teri A. Longacre, MD , George A. Fisher, MD , Sanjiv S. Gambhir, MD, PhD , 7 3,8 George A. Poultsides, MD , and Eben L. Rosenthal, MD, FACS Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA; 2 3 Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Otolaryngology, 4 5 Stanford University, Stanford, CA; Department of Pathology, Stanford University, Stanford, CA; Department of Medical Oncology, Stanford University, Stanford, CA; Departments of Radiology, Bioengineering, and Materials Science & Engineering, Molecular Imaging Program

Journal

Annals of Surgical Oncology – Springer Journals

Published: Apr 17, 2018

References

  • Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy
    Christians, KK
  • Neoadjuvant radiotherapeutic strategies in pancreatic cancer
    Roeder, F
  • Value of regional lymphadenectomy in pancreatic cancer
    Bassi, C
  • Pancreatic resection for pancreatic cancer
    Bachmann, J
  • Dramatic survival benefit related to R0 resection of pancreatic adenocarcinoma in patients with tumor ≤ 25 mm in size and ≤ 1 involved lymph nodes
    Tummala, P; Howard, T; Agarwal, B
  • Resection margin involvement and tumour origin in pancreatic head cancer
    Verbeke, CS; Gladhaug, IP
  • Influence of perineural invasion on survival and recurrence in patients with resected pancreatic cancer
    Zhang, JF
  • Light in and sound out: emerging translational strategies for photoacoustic imaging
    Zackrisson, S; Ven, SM; Gambhir, SS
  • Image-guided cancer surgery using near-infrared fluorescence
    Vahrmeijer, AL
  • Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light
    Hutteman, M
  • Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique
    Bloomston, M
  • Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer
    Uegaki, K
  • Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma
    Tummers, WS; Boonstra, MC; Prevoo, HA
  • IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques
    Zinn, KR
  • Deep tissue photoacoustic imaging using a miniaturized 2-D capacitive micromachined ultrasonic transducer array
    Kothapalli, SR
  • Evaluation of the relationship between cetuximab therapy and corrected QT interval changes in patients with advanced malignancies from solid tumors
    Deeken, JF
  • Survival benefit of extended resection in pancreatic cancer
    Buchler, P; Müller, M; AlKhatib, J; Buchler, MW
  • Preoperative characteristics of patients with presumed pancreatic cancer but ultimately benign disease: a multicenter series of 344 pancreatoduodenectomies
    Gerritsen, A
  • Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
    Cohen, R
  • Targeted therapies for pancreatic cancer
    Philip, PA
  • Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
    Heinemann, V
  • Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
    Hoff, DD
  • Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
    Moore, MJ
  • Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
    Mitry, E
  • Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
    Adiseshaiah, PP